Search results for "relationship"

showing 10 items of 3616 documents

Promoting Children's Wellbeing. Policies, Practices and Current Trends

2015

Abstract Mastering emotions and developing relationship skills are considered vital in this century of change. The current study meets the need of active experimentation with new ways of building educational relationships at early ages. The chosen theme is relevant and timely for both theory and educational practice. An innovation of the relationship models that is to place an accent on children's involvement and value in the educational process is required. We appreciate that we cannot value the voice of children in their absence. A re-examination and reconstruction of adult attitudes to create a better world for children becomes the new trend.

Value (ethics)Process (engineering)“professional training”Professional developmentPedagogyGeneral Materials Science“children's needs”Psychology“children's wellbeing”“educational relationships”.Accent (sociolinguistics)Theme (narrative)Procedia - Social and Behavioral Sciences
researchProduct

Revisiting the patient–physician relationship under the lens of value co-creation and defensive medicine

2021

PurposeThis study formulates a new archetypical model that describes and re-interprets the patient–physician relationship from the perspective of two widespread phenomena in the healthcare delivery process: value co-creation (VCC) and defensive medicine (DM).Design/methodology/approachGrounded in the existing literature on VCC and DM, the authors designed and conducted 20 in-depth interviews with doctors (and patients) about their past relationships with patients (and doctors). After putting the recorded interviews through qualitative analysis with a three-level coding activity, the authors built an empirically informed model to classify patient–physician relationships.FindingsThe authors i…

Value (ethics)Service (systems architecture)Value co-creationbusiness.industryStrategy and ManagementDefensive medicine05 social sciencesPerspective (graphical)Applied psychologyPersonalizationDefensive medicine0502 economics and businessHealth careCo-creationPatient–physician relationship050211 marketingbusinessPsychologyArchetype050203 business & managementJournal of Service Theory and Practice
researchProduct

Classification of Target Markets and Features of Segmentation in Marketing Places

2008

This paper examines target markets and the strategy of marketing places as an economic instrument directed to the development of countries, regions, cities and towns. The authors give a classification of potential target markets of a territory and their characteristics on an example of Latvia.Markets’ segmentation for realizing the strategy of marketing places is of great value as it allows concentrating activity on the most perspective directions of territory development and on methods of particular group attraction. It gives an opportunity to work with separate categories of consumers, to make marketing policy more direct and more expressive, to promote competitiveness of a territory and …

Value (ethics)lcsh:Commercelcsh:HB71-74business.industrylcsh:Economics as a scienceCustomer relationship managementMarket liquiditylcsh:HF1-6182Work (electrical)Leverage (negotiation)Return on equityProduction (economics)Strategic managementBusinessMarketingGeneral Economics Econometrics and FinanceEkonomika
researchProduct

The relationship between Value Co-creation and Defensive Medicine

The purpose of this study is to analyse the patient-physician relationship from the perspective of its consequences in terms of risk of defensive medicine behaviour and of likelihood of value co-creation occurrence. We develop, first, a theoretically informed model which explains the patient-physician relationship in terms of the two phenomena above mentioned; we then collect qualitative empirical data, elaborate on the theory, and develop an empirically informed model. The main result of this research is the definition of four archetypes of the patient-physician relationship, whose discussion leads to theoretical contributions and managerial implications.

Value co-creation Defensive medicine Patient-doctor relationshipSettore ING-IND/35 - Ingegneria Economico-Gestionale
researchProduct

The covalently immobilized antimicrobial peptide LL37 acts as a VEGF mimic and stimulates endothelial cell proliferation

2018

The chemical coupling of growth factors to solid substrates are discussed as an alternative to delivery systems. Utilizing entire proteins for this application is hampered by safety and stability considerations. Instead, growth factor mimicking peptides are of great interest for biomedical applications, such as tissue engineering, due to their purity and stability. The human cathelicidin derived antimicrobial peptide LL37, beside its microbicidal activity, was shown to stimulate endothelial cell growth when used in a soluble form. Here, in a novel approach, spacer mediated immobilization, but not direct conjugation of LL37, to a gold substrate was shown to result in a pronounced mitogenic e…

Vascular Endothelial Growth Factor A0301 basic medicinemedicine.medical_treatmentBiophysicsPeptideBiochemistryCathelicidin03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTissue engineeringCathelicidinsmedicineHumansMolecular BiologyCells CulturedCell Proliferationchemistry.chemical_classificationDose-Response Relationship DrugCell growthGrowth factorEndothelial CellsCell BiologyVascular endothelial growth factorEndothelial stem cellVascular endothelial growth factor A030104 developmental biologychemistry030220 oncology & carcinogenesisBiophysicsAdsorptionGoldAntimicrobial Cationic PeptidesBiochemical and Biophysical Research Communications
researchProduct

Synthesis of Combretastatin A-4 and 3′-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of their Interaction with Tub…

2020

Natural product combretastatin A-4 (CA-4) and its nitrogenated analogue 3&prime

Vascular Endothelial Growth Factor ACell cycle checkpoint<i>htert</i>Pharmaceutical ScienceApoptosisAnalytical Chemistrychemistry.chemical_compound0302 clinical medicineDrug DiscoveryStilbenesc-<i>myc</i>Telomerase0303 health sciences<i>vegf</i>biologyNeovascularization PathologicChemistry3′-aminocombretastatin a-4Cell cycle<i>c-Myc</i>VEGFc-MycBiochemistryChemistry (miscellaneous)030220 oncology & carcinogenesisMCF-7 CellsMolecular Medicinecytotoxicitycell cyclehTERTHT29 CellsArticleProto-Oncogene Proteins c-mycmicrotubuleslcsh:QD241-44103 medical and health sciencesStructure-Activity Relationshiplcsh:Organic chemistryMicrotubuleCell Line TumorHumansPhysical and Theoretical Chemistry030304 developmental biologyCell ProliferationCombretastatinCombretastatin A-4Cell growthOrganic ChemistryAntineoplastic Agents PhytogenicTubulintubulinCell cultureA549 Cellsbiology.proteinM Phase Cell Cycle Checkpointscombretastatin a-4Drug Screening Assays AntitumorMolecules
researchProduct

Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.

2010

Aims Currently, it is still unclear which mechanisms drive metabolic benefits after angiogenic gene therapy. The side-effect profile of efficient angiogenic gene therapy is also currently incompletely understood. In this study, the effects of increasing doses of adenoviral (Ad) vascular endothelial growth factor-A (VEGF-A) were evaluated on vascular growth, metabolic benefits, and systemic side effects. Methods and results Adenoviral vascular endothelial growth factor-A or AdLacZ control was injected intramuscularly (109–1011 vp/mL) or intra-arterially (5 × 1011 vp/mL) into rabbit ( n = 102) hindlimb muscles and examined 6 or 14 days later. Blood flow, tissue oedema, metabolic benefits, and…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisGenetic VectorsNeovascularization PhysiologicEnzyme-Linked Immunosorbent Assayta3111Injections IntramuscularAdenoviridaeNeovascularizationchemistry.chemical_compoundInternal medicinemedicineAnimalsMuscle SkeletalUltrasonography InterventionalSprouting angiogenesisDose-Response Relationship Drugbusiness.industryGene Transfer TechniquesMetabolic acidosisGenetic Therapymedicine.diseaseCapillariesHindlimbVascular endothelial growth factorVascular endothelial growth factor AEndocrinologychemistryLac OperonCirculatory systemRabbitsmedicine.symptomCardiology and Cardiovascular MedicinebusinessPerfusionEuropean heart journal
researchProduct

Benchmarking plant diversity of Palaearctic grasslands and other open habitats

2021

© 2021 The Authors.

Vascular plantSURROGATE333.7: Landflächen NaturerholungsgebieteBiomeLichenopen habitatPlant ScienceDATABASESBenchmarkGrasslandScale dependencebenchmarkRICHNESS HOTSPOTSVegetation typeTaxonomic rankSCALEMacroecologyComputingMilieux_MISCELLANEOUS2. Zero hungerbryophyteGLOBAL PATTERNSgeography.geographical_feature_categoryEcologyEcologyOpen habitatvascular plantForestryichenVegetationGrasslandVegetation plotPalaearctic580: Pflanzen (Botanik)GeographyHabitatscale dependencebenchmark; bryophyte; fine-grain biodiversity; grassland; GrassPlot Diversity Explorer; lichen; open habitat; Palaearctic; scale dependence; species–area relationship; vascular plant; vegetation plotLife Sciences & Biomedicinevegetation plotGrassPlot Diversity ExplorerCONSERVATIONEnvironmental Sciences & EcologylichenFine-grain biodiversitybenchmarkbenchmark bryophyte fine-grain biodiversity grassland GrassPlot Diversity Explorer lichen open habitat Palaearctic scale dependence species–area relationship vascular plant vegetation plotspecies-area relationship580benchmark bryophyte fine-grain biodiversity grassland GrassPlot Diversity Explorer lichen open habitat Palaearctic scale dependence species-area relationship vascular plant vegetation plotSpecies–area relationshipScience & Technologyfine-grain biodiversityPlant SciencesBiology and Life Sciences15. Life on landplant diversity13. Climate actionBryophyteSPECIES-AREA RELATIONSHIPSVASCULAR PLANTSBIODIVERSITYSpecies richness[SDE.BE]Environmental Sciences/Biodiversity and EcologygrasslandBRYOPHYTES
researchProduct

An In Vitro Experiment for Postmortem Vascular Permeation. The Passage of Morphine and Morphine Glucuronides Across a Vascular Wall

1997

A venous blood sample taken at autopsy cannot be considered to represent the antemortem blood concentration of a particular substance. Autolytic processes cause disintegration and increasing permeability of the physiological and anatomical barriers such as vascular walls and lead to changes in substance concentrations. In the present study, the experimental design represents an in vitro postmortem simulation of a drug substance crossing a venous wall. The postmortem behavior of morphine, morphine-3- and morphine-6-glucuronide was investigated. A Chien-Valia-diffusion chamber with a patch of inferior vena cava as diffusion barrier was used. For optimal simulation of postmortem events, vein s…

Vascular wallPathologymedicine.medical_specialtyVena Cava InferiorVascular permeabilityAutopsyInferior vena cavaPathology and Forensic MedicineGeneticsmedicineHumansVascular tissueFluorescent DyesMorphine DerivativesDose-Response Relationship DrugMorphineRhodaminesChemistryBiological TransportPenetration (firestop)Permeationmedicine.veinPostmortem ChangesAnesthesiaMorphineDiffusion Chambers CultureEndothelium Vascularmedicine.drugJournal of Forensic Sciences
researchProduct

Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).

2012

Identification, synthesis and structure-activity relationship of small-molecule VIPR1 antagonists encompassing two chemical series are described.

Vasoactive intestinal peptide (VIP)Settore MED/09 - Medicina InternaReceptors Vasoactive Intestinal Polypeptide Type IClinical BiochemistryVasoactive intestinal peptidePharmaceutical ScienceAntineoplastic AgentsThiophenesBiochemistrySmall Molecule LibrariesStructure-Activity RelationshipCell Line TumorDrug DiscoveryStructure–activity relationshipHumansReceptorMolecular BiologyChemistryVasoactive intestinal peptide receptorOrganic ChemistryBiphenyl CompoundsSmall Molecule LibrariesSmall moleculeHigh-Throughput Screening AssaysBiochemistryCell cultureVasoactive intestinal peptide receptor (VIPR)Molecular MedicineDrug Screening Assays AntitumorVIPR1Bioorganicmedicinal chemistry letters
researchProduct